My picks for 2017 have been the following :
-
Constellation Software (up 26%);
-
CGI Group (up 5%)
-
Alimentation Couche-Tard (up 8%);
-
Linamar (up 26%);
-
Knight Therapeutics (down 24%);
-
Tucows (up 79%);
-
United Therapeutics (up 4%);
-
Mohawk (up 37%);
-
Disney (up 2%);
-
LKQ (up 33%);
Average return : 19,6%
The returns above are
the returns of each stock, without the exchange rate between US dollar
and CAN dollar. Given the fact that the canadian dollar rose in 2017
(from 76 cents to 79 cents), the return of each american pick has
actually been a bit lower than what’s written up there.
The global return of my portfolio has been similar to these 10 picks (18%).
The return of the
S&P 500 has been : 19% and the return TSX/S&P 500 has
been about 5%. The Russel 2000 did about 13%. And the Dow Jones did
25%. There’s probably another index which could be appropriate but I’m
a little lost among all these indexes. In my opinion, my portfolio
should be compared with the TSX/S&P 500 (because my portfolio is 50% CAN and 50% US) so I’ve beaten the benchmark
by about 13% which is very good. Feel free to kneel in front of me. And
kiss my feet while you’re there.
Give me one year of good results and here I go: claiming blowjobs and not giving any insights about my Valeant years.
The stars of my
portfolio have been Tucows, Mohawk, LKQ, Constellation Software and
Linamar… But let’s not forget Credit Acceptance Corp (up 51%), Novo
Nordisk (up 50%) Dollar Tree (up 40%) and Ross Stores (up 23%) since the
beginning of the year.
My only bad pick was
Knight Therapeutics with a return of -24%. Which reminds me that we
should never bet on a speculative
stock and if we ever own any of these, it should be a small chunk of our
portfolio. I still own Knight Therapeutics but I may very well switch for
a business that really makes money in 2018.
That's probably the last post of 2017. Happy new year to everyone. For 2018, I wich you a transforming experience like swimming in the Ganges or some crazy thing like that. That's what money is for.